Candida vaginitis. Subacute and chronic vaginitis
Conditions
Interventions
Intervention 1: The intervention group will use the vaginal gel of gerbera prepared by the pharmacist with a concentration of 3%. After manufacturing, it is poured into sterilized tubes and placed in
Sponsors
Yasouj University of Medical Sciences
Vice President of Research and Technology of Yasouj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: 1- Women of reproductive age (18-49)- 2- Presence of cheesy vaginal discharge and doctor's confirmation 3- Complaints of burning, itching and swelling and pain in the vulva and vagina 4- Absence of other vaginal infections 5- Willingness to participate in the study 6- Women with sexual partners
Exclusion criteria
Exclusion criteria: 1- Lactating women 2- Pregnant women 3- Women who smoke 4- The possibility of starting menstruation in the next 10 days 5- Having abnormal vaginal bleeding at the time of sampling 6- Having intercourse in the last 24 hours 7- Washing the vagina and using vaginal medicine in the last 48 hours 8- Having a history of any type of transplantation and using immunosuppressive drugs and broad-spectrum antibiotics, hormonal drugs and combined contraceptive pills, anti prostaglandins and anticoagulant drugs in the last month, and antiepileptic and migraine drugs or women with Heart and kidney diseases or sexually transmitted diseases. 9- History of Candida infection in the last 6 months and its treatment 10- History of candidal vaginitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Itching. Timepoint: Results will be measured ten days to two weeks after the end of the treatment period. Method of measurement: The way to measure the variable will be through a laboratory test and also a researcher-made questionnaire of clinical symptoms.;Burning. Timepoint: Results will be measured ten days to two weeks after the end of the treatment period. Method of measurement: The way to measure the variable will be through a laboratory test and also a researcher-made questionnaire of clinical symptoms.;Vaginal pain. Timepoint: Results will be measured ten days to two weeks after the end of the treatment period. Method of measurement: The way to measure the variable will be through a laboratory test and also a researcher-made questionnaire of clinical symptoms.;Inflammation. Timepoint: Results will be measured ten days to two weeks after the end of the treatment period. Method of measurement: The way to measure the variable will be through a laboratory test and also a researcher-made questionnaire of clinical symptoms.;Cheesy secretions. Timepoint: Results will be measured ten days to two weeks after the end of the treatment period. Method of measurement: The way to measure the variable will be through a laboratory test and also a researcher-made questionnaire of clinical symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with treatment. Timepoint: One week to ten days after the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Bozorgian
Yasouj University of Medical Sciences
Outcome results
None listed